The University of Oxford has begun the world’s first human clinical trial of a vaccine targeting the Bundibugyo strain of Ebola, according to Bloomberg.
The trial comes as an outbreak in central Africa continues and has killed more than 700 people.
Oxford Starts First Human Trial of Bundibugyo Ebola Vaccine as Congo Outbreak Continues
2026-07-14 01:02:14
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
世界杯 | 德尚：法国战西班牙将精彩
